0
Signin
countryflagUS

18889881171

AAPL 174.545 3.0981% MSFT 400.8 -1.3585% GOOG 168.575 -2.9449% GOOGL 166.78 -3.0067% AMZN 180.55 0.5178% NVDA 872.0 -0.6098% META 432.1 -2.5243% TSLA 193.965 15.2564% TSM 137.52 -0.564% LLY 735.26 0.2386% V 272.48 -0.7431% AVGO 1336.05 -0.5967% JPM 193.42 -0.0362% UNH 490.57 -0.965% NVO 127.045 0.1537% WMT 60.075 -0.1413% LVMUY 167.187 -1.2422% XOM 119.54 1.3394% LVMHF 834.7 -1.2014% MA 457.31 -1.1051%

Inari Medical Inc

Healthcare US NARI

38.7USD
0.28(0.73%)

Last update at 2024-04-29T17:22:00Z

Day Range

37.3239.26
LowHigh

52 Week Range

47.8171.85
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -26.18500M 10.69M 13.79M -1.19182M -10.15300M
Minority interest - - - - -
Net income -29.26700M 9.84M 13.79M -1.90712M -10.15300M
Selling general administrative 292.84M 190.37M 89.75M 37.20M 10.70M
Selling and marketing expenses - - - - 0.00009M
Gross profit 338.96M 252.23M 126.56M 45.22M 5.55M
Reconciled depreciation 7.12M 4.31M 1.39M 0.61M 0.28M
Ebit -28.09900M 6.67M 18.42M 0.80M -9.18100M
Ebitda -18.77200M 10.98M 18.24M 1.30M -8.89800M
Depreciation and amortization 9.33M 4.31M -0.17800M 0.50M 0.28M
Non operating income net other - -0.15900M -4.63000M - -
Operating income -28.09900M 6.67M 18.42M 0.80M -9.14000M
Other operating expenses 411.57M 266.14M 121.25M 50.33M 15.97M
Interest expense 0.29M 0.29M 1.14M 0.92M 0.89M
Tax provision 3.08M 0.84M - - -
Interest income 1.85M 0.15M 0.48M 0.09M 0.09M
Net interest income 1.56M -0.14100M -0.65100M -0.83135M -0.79510M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.08M 0.84M -0.91200M 0.72M -0.12600M
Total revenue 383.47M 276.98M 139.67M 51.13M 6.83M
Total operating expenses 367.06M 241.38M 108.14M 44.42M 14.69M
Cost of revenue 44.51M 24.76M 13.11M 5.91M 1.28M
Total other income expense net 1.91M 4.01M -4.63000M -1.99332M -0.21800M
Discontinued operations - - - - -
Net income from continuing ops -29.26700M 9.84M 13.79M -1.19182M -10.15269M
Net income applicable to common shares -29.26700M 9.84M 13.79M -1.19200M -10.15300M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 504.15M 311.54M 214.09M 44.55M 26.90M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 5.31M 5.69M 2.86M 0.51M 0.81M
Total liab 87.15M 72.33M 13.84M 83.69M 66.35M
Total stockholder equity 417.00M 239.21M 200.25M -39.14384M -39.44554M
Deferred long term liab 0.05M 0.29M 0.38M 1.47M -
Other current liab 47.20M 35.17M 10.79M 6.32M 1.41M
Common stock 0.05M 0.05M 0.05M 0.00672M 0.00631M
Capital stock 0.05M 0.05M 0.05M 0.00672M 0.00631M
Retained earnings -46.85000M -17.58300M -27.42300M -41.21181M -40.12353M
Other liab - 1.42M - - -
Good will - - - - -
Other assets 0.59M 0.98M 0.92M 1.81M 0.02M
Cash 60.22M 92.75M 114.23M 23.64M 21.83M
Cash and equivalents - - - - -
Total current liabilities 56.17M 42.51M 13.84M 8.87M 2.13M
Current deferred revenue - - - - -
Net debt -27.93500M -63.54600M -114.22900M -4.15863M -11.99733M
Short term debt 1.31M 0.80M - - -
Short long term debt - - - - -
Short long term debt total 32.29M 29.21M - 19.48M 9.84M
Other stockholder equity 462.95M 257.14M 227.62M 2.06M 1.73M
Property plant equipment 72.36M 16.47M 7.50M 3.33M 0.92M
Total current assets 422.90M 245.20M 205.67M 39.41M 25.96M
Long term investments 0.00000M 3.98M - - -
Net tangible assets 417.00M 239.21M 200.25M -39.14400M -39.44554M
Short term investments 266.18M 83.35M 49.98M - -
Net receivables 58.61M 42.35M 28.01M 11.30M 2.23M
Long term debt - - - 19.48M 9.84M
Inventory 32.58M 21.05M 10.60M 3.95M 1.09M
Accounts payable 7.66M 6.54M 3.05M 2.55M 0.71M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.85M -0.40200M 0.00400M -1.27914M -1.06087M
Additional paid in capital - - - - -
Common stock total equity - 0.05M 0.05M 0.00672M 0.00631M
Preferred stock total equity - - - - -
Retained earnings total equity - -17.58300M -27.42300M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 8.89M 0.98M 0.92M 1.81M 0.02M
Deferred long term asset charges - - - - -
Non current assets total 81.25M 66.34M 8.42M 5.14M 0.94M
Capital lease obligations 32.29M 29.21M - - -
Long term debt total - - - 19.48M 9.84M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -195.21600M -37.37700M -55.43700M -49.97700M -49.97700M
Change to liabilities 1.14M 3.51M 0.50M 1.83M 0.37M
Total cashflows from investing activities -195.21600M -51.02200M -55.43700M -3.14400M -0.75300M
Net borrowings - - -20.25000M 9.86M 9.86M
Total cash from financing activities 177.14M 4.07M 144.12M 10.22M 26.76M
Change to operating activities 6.11M 7.04M 1.68M 3.73M 0.83M
Net income -29.26700M 9.84M 13.79M -1.19182M -10.15300M
Change in cash -32.53000M -21.86500M 90.59M 2.14M 15.11M
Begin period cash flow 92.75M 114.62M 24.03M 21.88M 6.77M
End period cash flow 60.22M 92.75M 114.62M 24.03M 21.88M
Total cash from operating activities -13.97200M 25.49M 1.91M -4.93590M -10.89200M
Issuance of capital stock 174.40M 0.00000M 164.36M 0.00000M 26.92M
Depreciation 7.12M 4.31M 1.39M 0.61M 0.28M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -11.68800M -10.48800M -6.64400M -2.87384M -0.55800M
Change to account receivables -17.03000M -14.36100M -16.70600M -8.95482M -2.16500M
Sale purchase of stock 8.42M 5.56M 164.83M 0.13M 27.01M
Other cashflows from financing activities -5.67900M -1.48500M 10.00M 20.36M 26.76M
Change to netincome 29.50M 25.52M 7.73M 1.86M 0.39M
Capital expenditures 9.95M 13.64M 5.46M 3.14M 0.75M
Change receivables - -14.36100M -16.70600M - -
Cash flows other operating - 8.31M 1.68M - -
Exchange rate changes - -0.40200M - - -
Cash and cash equivalents changes - -21.86500M 90.59M - -
Change in working capital -21.46800M -14.30000M -21.16900M -6.25930M -1.52000M
Stock based compensation 28.67M 25.45M 3.52M 0.50M 0.25M
Other non cash items 0.97M 0.14M 0.18M 0.10M 0.11M
Free cash flow -23.92300M 11.84M -3.54800M -8.08004M -11.64500M

Fundamentals

  • Previous Close 38.42
  • Market Cap3784.27M
  • Volume732212
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.19700M
  • Revenue TTM469.31M
  • Revenue Per Share TTM8.41
  • Gross Profit TTM 338.96M
  • Diluted EPS TTM-0.05

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NARI
Inari Medical Inc		 0.28 0.73% 38.70 - 1428.57 7.94 8.01 7.04 275.66
ABT
Abbott Laboratories		 -0.455 0.42% 107.08 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 3.46 1.03% 339.07 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 1.28 1.60% 81.02 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.58 0.79% 72.59 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Inari Medical Inc

6001 Oak Canyon, Irvine, CA, United States, 92618

Key Executives

Name Title Year Born
Mr. William H. Hoffman CEO, Pres & Director 1967
Mr. Mitchell C. Hill Chief Financial Officer 1959
Mr. Andrew J. Hykes Chief Operating Officer 1973
Dr. Thomas M. Tu M.D. Chief Medical Officer 1973
Ms. Janet Byk VP of Fin. & Accounting NA
Ms. Angela Ahmad Gen. Counsel & Sec. NA
Mr. Eric Khairy Sr. VP of Marketing NA
Mr. John R. Borrell Sr. VP of Sales 1967
Ms. Dena Truelove VP of HR NA
Ms. Tara Dunn Sr. VP of Clinical Affairs & Market Devel. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).